Abstract: A method and system for enhancing user engagement during wellness program interaction includes presenting health information to the user, collecting data and modifying the information presented to the user in enhance the user's engagement with the wellness program.

Abstract: A method and system for enhancing user engagement during wellness program interaction includes presenting health information to the user, collecting data and modifying the information presented to the user in enhance the user's engagement with the wellness program.

Abstract: A method and system for assessing user engagement during wellness program interaction are disclosed.

Abstract: A method and system for enhancing user engagement during wellness program interaction are disclosed.

Abstract: A method and system for providing personalized message delivery to one or more individual users of at least one team of users is disclosed. In accordance with the method and system, data specific to one or more individual users of at least one team of users is gathered, analyzed and used to determine preferences and order of precedence of the one or more individual users of the at least one team of users; and personalized message delivery is provided to the one or more individual users of the at least one team of users based upon the one or more individual users of the at least one team of users' preferences and order of precedence.

Abstract: A method and system for providing personalized message delivery to a user is disclosed. In accordance with the method and system, data specific to a user is gathered, analyzed and used to determine preferences and order of precedence of the user; and personalized message delivery is provided based upon the user's preferences and order of precedence.

Abstract: A method and system for conducting a health risk assessment of one or more individuals are disclosed. In accordance with the method and system, previous responses by multiple users are used to generate specific inquires for the individual to provide specific recommended action to the individual.

Abstract: A method is provided for determining the eating restraint behavior of an individual and communicating a recommendation to the individual based on the eating restraint behavior for compositions to consume that effective for the diagnosed eating restraint behavior. Such compositions effective for low rigid restraint eaters include soluble fiber and a multivalent cation.

Abstract: The present invention provides a method for incorporating long chain alcohols into edible oils. The long chain alcohol/edible oil admixture is then suitable for use in preparation of various foods. The long chain alcohol is added by the introduction of energy and in a preferred embodiment in the absence of surfactants and emulsifiers.

Abstract: A device for dispensing into a liquid at least one hydrophilic substance deposited thereon including a body having at least one surface area enhancer and at least one hydrophilic substance deposited on the at least one surface area enhancer, to form a coated surface enhancer, and the body. The hydrophilic substance deposited includes a high intensity sweetener, a nutritive sweetener, a flavoring agent, a drug substance, a vitamin, a mineral, and mixtures thereof.

Abstract: The present invention is directed to the encapsulation of long chain alcohols, C20-C36, in various materials including polymers and waxes. Through the proper selection of the polymer the encapsulated long chain alcohol can be advantageously added to foods such as margarines, salad dressings and the like.

Abstract: A device for dispensing into a liquid at least one hydrophilic substance deposited thereon including a body having at least one surface area enhancer and at least one hydrophilic substance deposited on the at least one surface area enhancer, to form a coated surface enhancer, and the body. The hydrophilic substance deposited includes a high intensity sweetener, a nutritive sweetener, a flavoring agent, a drug substance, a vitamin, a mineral, and mixtures thereof.

Abstract: The present invention is directed to a composition for oral administration that includes chitosan and GMP, wherein the chitosan and GMP are in other than a cationic gum or polysaccharide/protein complex. Also included herein are methods for controlling appetite in humans and animals by orally administering a composition that includes chitosan and GMP, wherein the chitosan and GMP are in other than a cationic gum or polysaccharide/protein complex.

Abstract: A composition and a device for sweetening products including a sweetening solution, wherein the sweetening solution consists essentially of a high intensity sweetener and a solvent, and a spraying apparatus are disclosed.

Abstract: The present invention is directed to a composition for oral administration that includes chitosan and GMP, wherein the chitosan and GMP are in other than a cationic gum or polysaccharide/protein complex. Also included herein are methods for controlling appetite in humans and animals by orally administering a composition that includes chitosan and GMP, wherein the chitosan and GMP are in other than a cationic gum or polysaccharide/protein complex.

Abstract: The present invention is directed to the encapsulation of long chain alcohols, C20-C36, in various materials including polymers and waxes. Through the proper selection of the polymer the encapsulated long chain alcohol can be advantageously added to foods such as margarines, salad dressings and the like.

Abstract: The present invention is directed to the encapsulation of long chain alcohols, C20-C36, in various materials including polymers and waxes. Through the proper selection of the polymer the encapsulated long chain alcohol can be advantageously added to foods such as margarines, salad dressings and the like.

Abstract: The present invention provides a quick dissolving, readily broken substrate suitable for the addition of pharmaceutical agents for oral administration. A method for making the substrate is also disclosed.

Abstract: Microbially-stable liquid pharmaceutical suspensions for oral administration comprising a bismuth-containing pharmaceutical agent, benzoic acid, sorbic acid, a suspension system and water, and wherein said compositions have a pH within the range of from about 3.0 to about 5.5. These compositions are efficacious, and have good aesthetics and good storage stability.